E-LIB Suche - Ergebnisse für: CHARI

1

P42 HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RELAPSE..:

van de Donk, N. ; Rasche, L. ; Touzeau, C....
HemaSphere. 7 (2023) S2 - p. 34-34 , 2023

Link: https://doi.org/10.1097/..

2

P16 HEALTH-RELATED QUALITY OF LIFE FOR FRAIL TRANSPLANT-INE..:

Facon, T. ; Plesner, T. ; Usmani, S....
HemaSphere. 7 (2023) S2 - p. 18-19 , 2023

Link: https://doi.org/10.1097/..

3

CO129 Comparative Effectiveness of Teclistamab Versus Real-..:

Krishnan, A. ; Nooka, A. ; Chari, A....
Value in Health. 26 (2023) 12 - p. S37 , 2023

Link: https://doi.org/10.1016/..

4

P18 Adjusted Comparison of Teclistamab Versus Real-World Ph..:

Mateos, M.V. ; Chari, A. ; Usmani, S.Z....
Value in Health. 26 (2023) 12 - p. S5 , 2023

Link: https://doi.org/10.1016/..

5

EE660 Real-World Economic Burden and Healthcare Resource Ut..:

Chari, A. ; Lin, X. ; Ammann, E....
Value in Health. 26 (2023) 12 - p. S180 , 2023

Link: https://doi.org/10.1016/..

6

P31 SINGLE-AGENT BELANTAMAB MAFODOTIN IN PATIENTS WITH RELA..:

Nooka, A. ; Cohen, A. ; Lee, H....
HemaSphere. 7 (2023) S2 - p. 27-28 , 2023

Link: https://doi.org/10.1097/..

7

P29 PHASE 1/2 RESULTS OF TALQUETAMAB, A G PROTEIN-COUPLED R..:

Minnema, M.C. ; Chari, A. ; Touzeau, C....
HemaSphere. 7 (2023) S2 - p. 26-27 , 2023

Link: https://doi.org/10.1097/..

8

655 Survival and Quality of Life Following CSF Diversion in..:

Dhaliwal, J ; Ruiz-Perez, M ; Mihaela-Vasilica, A...
British Journal of Surgery. 110 (2023) Supplement_7 - p. , 2023

Link: https://doi.org/10.1093/..

9

B06: SUBCUTANEOUS TALQUETAMAB IN COMBINATION WITH DARATUMUM..:

Mateos, M ; Hari, P ; Bahlis, N...
HemaSphere. 6 (2022) - p. 9-9 , 2022

Link: https://doi.org/10.1097/..

10

P06: UPDATED RESULTS FROM THE PHASE 1/2 MAJESTEC-1 STUDY OF..:

Popat, R ; Usmani, S ; Garfall, A...
HemaSphere. 6 (2022) - p. 14-14 , 2022

Link: https://doi.org/10.1097/..

11

S188: TECLISTAMAB IN COMBINATION WITH DARATUMUMAB, A NOVEL,..:

Rodriguez Otero, P. ; D'Souza, A. ; Reece, D....
HemaSphere. 6 (2022) - p. 89-90 , 2022

Link: https://doi.org/10.1097/..

12

P921: UPDATED EFFICACY AND SAFETY RESULTS OF TECLISTAMAB, A..:

Martínez-López, J. ; Moreau, P. ; Usmani, S. Z....
HemaSphere. 6 (2022) - p. 811-812 , 2022

Link: https://doi.org/10.1097/..

13

P13: CAN PATIENT-REPORTED OCULAR SYMPTOMS GUIDE DOSE MODIFI..:

Popat, R ; Badros, A ; Kumar, S...
HemaSphere. 6 (2022) - p. 18-18 , 2022

Link: https://doi.org/10.1097/..

14

P934: DARATUMUMAB + LENALIDOMIDE, BORTEZOMIB, AND DEXAMETHA..:

Rodriguez, C. ; Kaufman, J. L. ; Laubach, J....
HemaSphere. 6 (2022) - p. 824-825 , 2022

Link: https://doi.org/10.1097/..

15

P10: TALQUETAMAB, A G PROTEIN-COUPLED RECEPTOR FAMILY C GRO..:

van de Donk, N. W. C. J ; Minnema, M C ; Berdeja, J G...
HemaSphere. 6 (2022) - p. 16-17 , 2022

Link: https://doi.org/10.1097/..